Yevgeniy Brailovsky, DO, MSc, FACC

Dara Steinberg, PhD, is an Assistant Professor of Medical Psychology jointly appointed in the departments of Pediatrics and Psychiatry. She serves as the Psychosocial Director in the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation. Dr. Steinberg specializes in pediatric psychology, working with children, adolescents, young adults, and their families, who have chronic and acute medical conditions, particularly oncological and hematological conditions. Dr. Steinberg uses evidenced-based treatment to address adjustment, adherence, and emotional and behavioral aspects of living with medical conditions. Her research interests focus on the interaction between physiological and psychological health and well-being. Dr. Steinberg graduated magna cum laude with a BA, with honors in psychology, from Brown University and went on to earn her Ph.D in clinical psychology from Ferkauf Graduate School of Psychology, Yeshiva University. She completed her clinical psychology internship and post-doctoral fellowship at Texas Children’s Hospital, Baylor College of Medicine.

Margaret McEntegart, MD, serves as Director of Complex PCI and CTO Programs at Columbia University Irving Medical Center, leading one of New York City’s premier programs for complex coronary care. She also holds the position of Director of the Cardiac Catheterization Laboratories at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.An internationally recognized clinician and researcher, Dr. McEntegart brings extensive experience to her work at Columbia. Before joining the institution, she was a consultant interventional cardiologist at Golden Jubilee National Hospital in Scotland, where she helped establish and lead the CTO and Complex PCI Program. She also directed the MitraClip service and contributed to the early development of the transcatheter aortic valve replacement (TAVR) program.Dr. McEntegart has played a central role as principal investigator in numerous clinical trials at local, national, and international levels. She co-supervised Ph.D. research fellows in interventional cardiology with Professor Colin Berry and founded the Glasgow Coronary Core Lab, which supported critical research efforts including the UK T-TIME trial and the BCIS-REVIVED study.At Columbia, Dr. McEntegart is committed to education and mentorship. She plays an active role in training interventional cardiology fellows, guiding junior faculty, and supporting professional development across the cardiovascular care team.

Dr. Kimberly Morel is an Associate Professor of Dermatology and Pediatrics at Columbia University Medical Center. She joined the staff of NewYork-Presbyterian Morgan Stanley Children's Hospital in 2003. Dr. Morel received her undergraduate degree from the University of Pennsylvania and her medical degree from SUNY Health Science Center at Brooklyn, New York. She completed her residency training in both Pediatrics and Dermatology at the New York Presbyterian Hospital/Columbia University and was a fellow in Pediatric and Adolescent Dermatology at the Children's Hospital, San Diego, University of California, San Diego. She is board certified in Pediatrics, Dermatology as well as Pediatric Dermatology. Dr. Morel directs the Pediatric Epidermolysis Bullosa (EB) Interdisciplinary Clinic at Columbia. The EB Clinic, which was initiated by Dr. Morel in June 2007, provides comprehensive outpatient consultation, consisting of various sub-specialists, such as dermatologists, occupational and physical tharapists, nutritionists, and social workers, who have expertise in treating the multiple aspects of EB. She is a also a member of the Vascular Anomalies Clinic (VAC) and the Pediatric Cutaneous Oncology Clinic (PCOC). Dr. Morel performs pulsed dye laser therapy for vascular birthmarks. She is the author of several articles and book chapters regarding skin conditions in pediatric patients. Dr. Morel is a fellow of the American Academy of Dermatology and the American Academy of Pediatrics. She is a member of the Society for Pediatric Dermatology, Hemangioma Investigator Group, the Epidermolysis Bullosa Clinical Research Concortium, and is on the executive committee of the Pediatric Dermatology Research Alliance (PeDRA).